Tags: walgreens | cvs | zantac | carcinogen

Walgreens, CVS Take Zantac Off Shelves as Carcinogen Probed

Walgreens, CVS Take Zantac Off Shelves as Carcinogen Probed

Monday, 30 September 2019 03:43 PM

Walgreens Boots Alliance Inc. will remove all versions of Zantac from its stores’ shelves as health regulators investigate a probable carcinogen detected in the popular stomach drugs.

Some Zantac products, known in generic form as ranitidine, have been recalled in the U.S., but pharmacies are beginning to halt sales of all the drugs until more is known about the levels of the carcinogen. On Saturday, CVS Health Corp. said it would stop selling all branded Zantac as well as its store brand ranitidine products.

Phil Caruso, a spokesman for Walgreens, told Bloomberg in an email Monday that the pharmacy chain would no longer be stocking the products. French pharmaceutical company Sanofi makes branded Zantac. Walgreens store-brand ranitidine was recalled last week by generic drugmaker Apotex Inc., which manufacturers the drug that is then packaged and labeled by the drugstore chain. Apotex also recalled ranitidine made for Walmart Inc. and Rite Aid Corp.

CVS said in a statement Saturday that it had suspended the sale of all branded Zantac and generics sold under the CVS label “out of an abundance of caution.” Sanofi’s Zantac and the generic version sold under the CVS name haven’t been recalled.

Novartis AG’s Sandoz unit recalled generic prescription ranitidine in the U.S. last week after detecting elevated levels of the carcinogen NDMA. The carcinogen is the same one that last year sparked a recall in about 30 countries of millions of blood-pressure pills called angiotensin II receptor blockers.

Novartis, GlaxoSmithKline Plc, and Dr. Reddy’s Laboratories Ltd. have halted global distribution of their versions of Zantac. French regulators, meanwhile, have ordered a recall of all Zantac and its generics available in pharmacies there.

© Copyright 2019 Bloomberg News. All rights reserved.

   
1Like our page
2Share
Companies
Walgreens Boots Alliance Inc. will remove all versions of Zantac from its stores' shelves as health regulators investigate a probable carcinogen detected in the popular stomach drugs.
walgreens, cvs, zantac, carcinogen
276
2019-43-30
Monday, 30 September 2019 03:43 PM
Newsmax Media, Inc.
 

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
MONEYNEWS.COM
© Newsmax Media, Inc.
All Rights Reserved